(Press-News.org) Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British Columbia.
The findings, published today in the New England Journal of Medicine, challenge current clinical practice guidelines and could change how bipolar depression is managed globally.
“Treating depression in bipolar disorder is challenging and the depressive episodes can be quite devastating for patients and their families,” said Dr. Lakshmi Yatham, professor and head of the department of psychiatry at UBC, and the study’s lead author. “Reducing the risk of relapse is important because it can provide patients with a great deal of stability that ultimately lets them get back to the activities they enjoy and can greatly improve their quality of life.”
Patients with bipolar disorder experience extreme changes in their emotional state that cycle through periods of intense highs (mania or hypomania) and lows (depression). During depressive episodes, patients can experience feelings of sadness, hopelessness and loss of interest or pleasure in activities, in addition to trouble sleeping, changes in appetite and suicidal thoughts.
Antidepressant adjunctive therapy – in which antidepressants are prescribed alongside mood stabilizers and/or second-generation antipsychotic medications – is a commonly used strategy by clinicians to treat depressive episodes. However, the duration of this therapy is hotly debated due to a lack of evidence and concerns that antidepressants may induce mania, mixed states or rapid cycling between mania and depression.
Practice guidelines for the management of bipolar disorder published by the Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) currently recommend discontinuing antidepressant treatment eight weeks after remission of depression.
“It’s an area that hasn’t been widely studied and there is not a lot of consensus among experts,” said Dr. Yatham. “Some studies have shown that up to 80 per cent of patients continue receiving antidepressants for six months or longer.”
Now, results from the world’s first randomized clinical trial assessing the duration of adjunctive antidepressant therapy suggest that extending the treatment period beyond current guidelines may help prevent depressive relapses.
The clinical trial, conducted at sites in Canada, South Korea and India, involved 178 patients with bipolar I disorder who were in remission from a depressive episode following treatment with modern antidepressant drugs (escitalopram or bupropion XL). The patients were randomly assigned to either continue antidepressant treatment for 52 weeks, or begin tapering off antidepressants at six weeks and switch to a placebo at eight weeks.
Over the year-long study, 46 per cent of patients in the placebo group experienced a relapse of a mood event, compared to only 31 per cent in the group that continued antidepressant treatment. While this primary outcome was not found to be statistically significant, the comparison included relapses that occurred during the first six weeks of the study when both groups were receiving the same treatment.
However, in an analysis from week six onward, when treatment between the two groups differed, patients that continued antidepressant treatment were 40 per cent less likely to experience a relapse of any mood event, and 59 per cent less likely to experience a depressive episode relative to the placebo group. There was no significant difference in the rate of manic episodes or the rate of adverse events between groups.
“From the point where the two groups began receiving different treatments, we see a significant benefit for patients who continued treatment with antidepressants,” said Dr. Yatham.
Patients with bipolar I disorder experience depressive symptoms three times more frequently than manic symptoms. Previous studies have shown that suicide attempts and suicide deaths are at least 18 times more common during depressive episodes compared to during manic episodes.
“Stabilizing patients and keeping them stable by preventing relapse is critical and can quite literally be lifesaving,” said Dr. Yatham. “Future revisions of bipolar guidelines will incorporate the evidence from this study and contribute to changes in clinical practice on how antidepressants will be used to manage patients with bipolar disorder.”
The study was a collaboration between researchers at UBC and other study sites in Canada, India and South Korea. It was supported by the Canadian Institutes of Health Research.
END
Modern antidepressants may reduce risk of relapse for patients with bipolar depression
2023-08-02
ELSE PRESS RELEASES FROM THIS DATE:
Scientists discover mechanisms that could explain high risk of complications from lung infections in Down syndrome
2023-08-02
AURORA, Colo. (August 2, 2023) – Individuals with Down syndrome, the genetic condition caused by triplication of human chromosome 21, also known as trisomy 21, display a very high risk of hospitalization and mortality after developing lung infections. Respiratory disease is second only to congenital heart defects as a cause of death among children with Down syndrome, and lower respiratory tract pathology is the most common cause of acute hospital admissions in this population. Furthermore, adults with Down syndrome have a much higher risk of hospitalization and death from COVID-19. Despite many research efforts, ...
Scientists view the “transition state” of a photochemical reaction in real-time
2023-08-02
The Science
In chemical reactions, molecules proceed during their transformation from reactants into reaction products through a critical geometry. In chemistry, geometry refers to the arrangement of atoms in a molecule. Scientists often call critical geometry in reactions a transition state. This state has an almost incomprehensibly short lifetime of less than one millionth of one millionth of a second. Scientists recently captured a critical geometry using the ultra-high speed “electron camera” at SLAC. In combination with quantum simulations of the reaction, ...
Scientists dig into wildfire predictions, long-term impacts
2023-08-02
Wildfires are an ancient force shaping the environment, but they have grown in frequency, range and intensity in response to a changing climate. At the Department of Energy’s Oak Ridge National Laboratory, scientists are working on several fronts to better understand and predict these events and what they mean for the carbon cycle and biodiversity.
Two months into the 2023 peak summer fire season from June through August, Canadian wildfires had burned more than 25 million acres of land, disrupted the lives of millions and spread beyond the traditional confines of western Canada east to Nova Scotia. The phenomenon attracted renewed attention as smoke drifted to heavily populated ...
Sea urchins are struggling to ‘get a grip’ as climate change alters ecosystems
2023-08-02
When driving through a rainstorm, traction is key. If your tires lack sufficient tread, your vehicle will slip and slide and you won’t have the grip needed to maneuver safely. When torrential rains hit nearshore, shallow water ecosystems, sea urchins experience a similar challenge. Heavy precipitation can alter the concentration of salt in the ocean waters causing lower salinity levels. Even a slight change in salinity can affect the ability of sea urchins to securely attach their tube feet to their surroundings – like tires gripping the road. This ...
When D turns to F, quantum matter is A-plus
2023-08-02
HOUSTON – (Aug. 2, 2023) – Rice University physicists have shown that immutable topological states, which are highly sought for quantum computing, can be entangled with other, manipulable quantum states in some materials.
“The surprising thing we found is that in a particular kind of crystal lattice, where electrons become stuck, the strongly coupled behavior of electrons in d atomic orbitals actually act like the f orbital systems of some heavy fermions,” said Qimiao Si, co-author of a study about the research in Science Advances.
The unexpected find provides ...
A novel strategy to suppress triple negative breast cancer growth
2023-08-02
In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies. Looking into the details of this novel role of MAPK4, the researchers have now identified a strategy that can potentially control MAPK4-promoted growth in TNBC and other cancers. The study, published in PLOS Biology, opens new options for treating this devastating disease.
“Some cancers depend on MAPK4 for their growth, and our team studies cellular processes or pathways that participate in ...
Super Radar: Breakthrough radar research overcomes a nearly century-old trade-off between wavelength and distance resolution
2023-08-02
New interference radar functions employed by a team of researchers from Chapman University and other institutions improve the distance resolution between objects using radar waves. The results may have important ramifications in military, construction, archaeology, mineralogy and many other domains of radar applications.
This first proof-of-principle experiment opens a new area of research with many possible applications that can be disruptive to the multi-billion dollar radar industry. There are many new avenues to pursue both in theory and experiment.
The ...
Study finds Black people less likely to be seen at memory clinic than white people
2023-08-02
MINNEAPOLIS – Black people and people living in less affluent neighborhoods—areas with higher poverty levels and fewer educational and employment opportunities— may be less likely to be seen at a memory care clinic compared to white people and people living in neighborhoods with fewer disadvantages, according to new research published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“Our results are concerning, especially ...
Bullying, suicidal thoughts linked to more frequent headaches in teens
2023-08-02
MINNEAPOLIS – Teens who have been bullied by their peers, or who have considered or attempted suicide, may be more likely to have more frequent headaches than teens who have not experienced any of these problems, according to a study published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that bullying or thoughts of suicide cause headaches; it only shows an association.
“Headaches are a common problem for teenagers, but our study looked beyond the biological factors to also consider the psychological and social factors that are associated with headaches,” ...
Study defines disparities in memory care
2023-08-02
Patients who live in less affluent neighborhoods and those from underrepresented racial or ethnic groups are less likely than others to receive specialized care for dementia, including Alzheimer’s disease, a new study from Washington University School of Medicine in St. Louis indicates. Further, the research shows that Black people are more likely than white people to be diagnosed with dementia at a later, more advanced stage, which could contribute to inequities in access to new treatments.
The study appears Aug. 2 in the journal Neurology.
New medications ...